Rochester, MNNCT06525740Now EnrollingIRB Ready

Malignant Female Reproductive System Neoplasm Clinical Trial in Rochester, MN

Access cutting-edge malignant female reproductive system neoplasm treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.

Sponsored by Mayo Clinic

Quick Self-Assessment

See if you qualify for this Rochester location

Preparing your pre-screening questions…

Expert Care in Rochester

Access malignant female reproductive system neoplasm specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related malignant female reproductive system neoplasm treatment provided free

Apply for This Rochester Location

Check if you qualify for this malignant female reproductive system neoplasm clinical trial in Rochester, MN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Rochester

    Convenient for MN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Rochester site if eligible
  4. 4Begin participation

About This Malignant Female Reproductive System Neoplasm Study in Rochester

This phase IV trial compares methadone versus hydromorphone given in the fluid-filled space between the thin layers of tissue that cover the brain and spinal cord (intrathecal) for postoperative pain relief in patients with gynecologic cancer undergo surgery. Methadone binds to opioid receptors in the central nervous system and is a long-acting opioid pain medication. Intrathecal hydromorphone works by changing the way the brain and nervous system respond to pain and is similar to an epidural. This trial may help researchers determine if methadone works as well as intrathecal hydromorphone for pain relief after surgery in patients with gynecologic cancer.

Sponsor: Mayo Clinic

Who Can Participate

Inclusion Criteria

Undergoing surgery with a laparotomy for gynecologic malignancy
Planned inpatient admission greater than 24 hours

Exclusion Criteria

Chronic pain requiring greater than 20 morphine milligram equivalents of opioid medications as an outpatient
Prolonged corrected QT interval (QTc) \> 500ms
Chronic kidney disease with estimated glomerular filtration rate (eGFR) \< 30 milliliters per minute (mL/min)
Documented cirrhosis
Preoperative platelets (PLT) \< 100
Preoperative international normalized ratio (INR) \> 1.1
Inappropriate cessation of anticoagulation medications prior to surgery
Intolerance to hydromorphone or methadone
Contraindication to administration of liposomal bupivacaine
Subsequent surgeries after index surgery

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Rochester?

Yes, this clinical trial (NCT06525740) has an active research site in Rochester, MN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Malignant Female Reproductive System Neoplasm Treatment Options in Rochester, MN

If you're searching for malignant female reproductive system neoplasm treatment options in Rochester, MN, this clinical trial (NCT06525740) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced malignant female reproductive system neoplasm specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all malignant female reproductive system neoplasm clinical trials near you to find additional studies recruiting in your area.

More Ulcerative Colitis Trials in Rochester, MN

See all ulcerative colitis clinical trials recruiting in Rochester — not just this study.

Browse Ulcerative Colitis Trials in Rochester

Ready to Join in Rochester?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Rochester, MN